Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of Dyadic Care to Support Clinical, Administrative, and Service Wraparound Needs for the Opioid-Exposed Mother and Infant.

Journal of addiction medicine·2026
Same author

Prenatal Opioid Exposure: Have We Lost an Opportunity to Improve the Outcomes of Mothers and Their Infants?

Clinical therapeutics·2025
Same author

Prenatal buprenorphine/naloxone exposure and neonatal neurobehavioral functioning: A preliminary report.

Neurotoxicology and teratology·2024
Same author

Gestational buprenorphine-naloxone exposure and fetal neurobehavior.

Neurotoxicology and teratology·2024
Same author

Clinically defining the opioid-exposed birthing person and infant as a dyad to support bedside care, surveillance, and research.

Frontiers in pediatrics·2024
Same author

Daily yogurt consumption does not affect bone turnover markers in men and postmenopausal women of Caribbean Latino descent: a randomized controlled trial.

BMC nutrition·2024
Same journal

For health, for beauty, or both? navigating trends as adolescent clinicians.

Current opinion in pediatrics·2026
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
See all related articles

Related Experiment Video

Updated: May 26, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Neonatal abstinence syndrome.

Lauren M Jansson1, Martha Velez

  • 1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA. ljansson@jhmi.edu

Current Opinion in Pediatrics
|January 10, 2012
PubMed
Summary
This summary is machine-generated.

Neonatal Abstinence Syndrome (NAS) presentation is complex, influenced by maternal and environmental factors. Buprenorphine may reduce NAS severity compared to methadone during pregnancy.

More Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

Related Experiment Videos

Last Updated: May 26, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

Area of Science:

  • Neonatal Abstinence Syndrome (NAS)
  • Pharmacology
  • Maternal-Fetal Medicine

Background:

  • Neonatal Abstinence Syndrome (NAS) is traditionally linked to gestational opioid exposure.
  • Emerging research indicates other substances, like serotonin reuptake inhibitors, can cause discontinuation syndromes.
  • Variability in NAS presentation suggests complex interactions between prenatal and postnatal factors.

Purpose of the Study:

  • To review the multifaceted factors influencing neonatal abstinence syndrome (NAS) presentation.
  • To discuss clinical presentation and treatment of NAS.
  • To explore recent findings and their impact on future NAS research.

Main Methods:

  • Literature review of recent findings on neonatal abstinence syndrome (NAS).
  • Analysis of maternal, fetal, and infant factors affecting NAS expression.
  • Evaluation of current and alternative treatment modalities for opioid-dependent pregnancies.

Main Results:

  • Recent research has expanded the understanding of NAS beyond opioid withdrawal.
  • Prenatal and postnatal environmental and genetic factors significantly influence NAS variability.
  • Buprenorphine shows promise as an alternative to methadone, potentially reducing NAS severity.

Conclusions:

  • Healthcare providers must recognize the complexity of factors contributing to NAS.
  • Comprehensive assessment and care for the mother-infant dyad are crucial.
  • Further research into NAS pathophysiology and treatment is essential.